These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10398105)
21. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions. Kuźbicki L; Gajo B; Chwirot BW Melanoma Res; 2006 Jun; 16(3):235-43. PubMed ID: 16718270 [TBL] [Abstract][Full Text] [Related]
22. Systematic search for the best gene expression markers for melanoma micrometastasis detection. Soikkeli J; Lukk M; Nummela P; Virolainen S; Jahkola T; Katainen R; Harju L; Ukkonen E; Saksela O; Hölttä E J Pathol; 2007 Oct; 213(2):180-9. PubMed ID: 17891747 [TBL] [Abstract][Full Text] [Related]
23. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas. Fröhlich E; Mack AF; Garbe C; Klessen C Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients. Garbe C; Leiter U; Ellwanger U; Blaheta HJ; Meier F; Rassner G; Schittek B Cancer; 2003 Apr; 97(7):1737-45. PubMed ID: 12655531 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623 [TBL] [Abstract][Full Text] [Related]
27. Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. De Vries TJ; De Wit PE; Clemmensen I; Verspaget HW; Weidle UH; Bröcker EB; Ruiter DJ; Van Muijen GN J Pathol; 1996 Jul; 179(3):260-5. PubMed ID: 8774480 [TBL] [Abstract][Full Text] [Related]
28. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256 [TBL] [Abstract][Full Text] [Related]
29. Functional role of MIA in melanocytes and early development of melanoma. Poser I; Tatzel J; Kuphal S; Bosserhoff AK Oncogene; 2004 Aug; 23(36):6115-24. PubMed ID: 15208686 [TBL] [Abstract][Full Text] [Related]
30. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687 [TBL] [Abstract][Full Text] [Related]
31. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma. Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257 [TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 expression in melanocytic lesions of the skin. Ramirez JA; Guitart J; Rao MS; Diaz LK Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449 [TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. de Giorgi V; Mavilia C; Massi D; Gozzini A; Aragona P; Tanini A; Sestini S; Paglierani M; Boddi V; Brandi ML; Lotti T Arch Dermatol; 2009 Jan; 145(1):30-6. PubMed ID: 19153340 [TBL] [Abstract][Full Text] [Related]
34. Expression of neurotrophins and their receptors in pigment cell lesions of the skin. Innominato PF; Libbrecht L; van den Oord JJ J Pathol; 2001 May; 194(1):95-100. PubMed ID: 11329147 [TBL] [Abstract][Full Text] [Related]
35. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097 [TBL] [Abstract][Full Text] [Related]
36. p54nrb is a new regulator of progression of malignant melanoma. Schiffner S; Zimara N; Schmid R; Bosserhoff AK Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354 [TBL] [Abstract][Full Text] [Related]
37. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression? Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845 [TBL] [Abstract][Full Text] [Related]
38. Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases. Deichmann M; Polychronidis M; Benner A; Kleist C; Thome M; Kahle B; Helmke BM Int J Oncol; 2004 Aug; 25(2):259-68. PubMed ID: 15254721 [TBL] [Abstract][Full Text] [Related]
39. Clinicopathological implications of parathyroid hormone-related protein in human colorectal tumours. Nishihara M; Ito M; Tomioka T; Ohtsuru A; Taguchi T; Kanematsu T J Pathol; 1999 Jan; 187(2):217-22. PubMed ID: 10365097 [TBL] [Abstract][Full Text] [Related]
40. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions. Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]